50824 Federal Register / Vol. 73, No. 168 / Thursday, August 28, 2008 / Notices 

Pneumococcal Vaccine 

Mild Problems: During studies of the 

vaccine, some children became fussy or 

drowsy or lost their appetite. 

Rotavirus Vaccine 

Mild Problems: Children who get 

rotavirus vaccine are slightly more 

likely than other children to have mild, 

temporary diarrhea or vomiting. This 

happens within the first week after 

getting a dose of vaccine. No moderate 

or serious problems have been 

associated with the vaccine. 

Precautions 

If your child is sick on the date 

vaccinations are scheduled, your 

provider may want to put them off until 

she recovers. A child with a mild cold 

or a low fever can usually be vaccinated 

that day. But for a more serious 

illnesses, it may be better to wait. 

Some children should not get certain 

vaccines. Talk with your provider if 

your child had a serious reaction after 

a previous dose of a vaccine, or has any 

life-threatening allergies. (These 

reactions and allergies are rare.) 

If your child had any of these 

reactions to a previous dose of DTaP: 

—A brain or nervous system disease 

within 7 days 

—Non-stop crying for 3 or more hours 

—A seizure or collapse 

—A fever over 105°F 

Talk to your provider before getting 

DTaP Vaccine. 

If your child has: 

—A life-threatening allergy to the 

antibiotics neomycin, streptomycin, 

or polymyxin B. 

Talk to your provider before getting 

Polio Vaccine. 

If your child has: 

—A life-threatening allergy to yeast 

Talk to your provider before getting 

Hepatitis B Vaccine. 

If your child has: 

—A weakened immune system 

—Ongoing digestive problems 

—Recently gotten a blood transfusion or 

other blood product 

—Ever had intussusception (an 

uncommon type of intestinal 

obstruction) 

Talk to your provider before getting 

Rotavirus Vaccine. 

What if my child has a moderate or 

severe reaction? 

What should I look for? 

Look for any unusual condition, such 

as a serious allergic reaction, high fever, 

weakness, or unusual behavior. 

Serious allergic reactions are 

extremely rare with any vaccine. If one 

were to happen, it would most likely 

come within a few minutes to a few 

hours after the shot. 

Signs of a serious allergic reaction can 

include: 

—difficulty breathing 

—weakness 

—hives 

—hoarseness or wheezing 

—dizziness 

—paleness 

—swelling of the throat 

—fast heart beat 

What should I do? 

Call a doctor, or get the child to a 

doctor right away. 

Tell your doctor what happened, the 

date and time it happened, and when 

the shot was given. 

Ask your healthcare provider to report 

the reaction by filing a Vaccine Adverse 

Event Reporting System (VAERS) form. 

Or you can file this report through the 

VAERS Web site at http:// 

www.vaers.hhs.gov, or by calling 1–800–

822–7967. 

VAERS does not provide medical 

advice. 

The National Vaccine Injury 

Compensation Program 

A federal program exists to help pay 

for the care of anyone who has a serious 

reaction to a vaccine. 

For information about the National 

Vaccine Injury Compensation Program, 

call 1–800–338–2382 or visit their Web 

site at http://www.hrsa.gov/ 

vaccinecompensation. 

For More Information 

Ask your healthcare provider. They 

can give you the vaccine package insert 

or suggest other sources of information. 

Call your local or state health 

department. 

Contact the Centers for Disease 

Control and Prevention (CDC) at 1–800–

232–4636 (1–800–CDC–INFO) . 

Visit CDC Web sites at: http:// 

www.cdc.gov/vaccines and http:// 

www.cdc.gov/ncidod/diseases/hepatitis. 

Dated: August 20, 2008. 

James D. Seligman, 

Chief Information Officer, Centers for Disease 

Control and Prevention (CDC). 

[FR Doc. E8–19965 Filed 8–27–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Health Statistics 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), National 

Center for Health Statistics (NCHS) 

announces the following meeting of the 

aforementioned committee. 

Times and Dates: 11 a.m.–5:30 p.m., 

September 18, 2008. 8:30 a.m.–2 p.m., 

September 19, 2008. 

Place: NCHS Headquarters, 3311 Toledo 

Road, Hyattsville, Maryland 20782. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 100 people. 

Purpose: This committee is charged with 

providing advice and making 

recommendations to the Secretary, 

Department of Health and Human Services; 

the Director, CDC; and the Director, NCHS, 

regarding the scientific and technical 

program goals and objectives, strategies, and 

priorities of NCHS. 

Matters To Be Discussed: The agenda will 

include welcome remarks by the Director, 

NCHS; introduction of members and key 

NCHS staff; scientific presentations and 

discussions; the review of the National 

Health Interview Survey; presentation of the 

long term care program in the initial stage of 

review; and an open session for comments 

from the public. 

Requests to make oral presentations should 

be submitted in writing to the contact person 

listed below. All requests must contain the 

name, address, telephone number, and 

organizational affiliation of the presenter. 

Written comments should not exceed five 

single-spaced typed pages in length and must 

be received by September 12, 2008. 

The agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Virginia S. Cain, Ph.D., Director of 

Extramural Research, NCHS/CDC, 3311 

Toledo Road, Room 7211, Hyattsville, 

Maryland 20782, telephone (301) 458–4500, 

fax (301) 458–4020. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: August 22, 2008. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E8–19947 Filed 8–27–08; 8:45 am] 

BILLING CODE 4163–18–P 


jlentini on PROD1PC65 with NOTICES